U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. BAT (Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)
  1. Approved Blood Products

BAT (Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)

STN#: 125462
Proper Name: Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)
Tradename: BAT
Manufacturer: Cangene Corporation
Indication:

  • For the treatment of symptomatic botulism following documented or suspected exposure to botulinum neurotoxin serotypes A, B, C, D, E, F, or G in adults and pediatric patients.

Product Information

Supporting Documents

Back to Top